Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01826071 · ClinicalTrials.gov registry record · NA

Comparison of Three Treatments for Lower Extremity Apophysitis

A NA study of Osgood-Schlatter Syndrome (OSS) and Sinding-Larson and Johansson Syndrome (SLJ), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Completed
Registry status
NA
Development phase
129
Enrollment target
1
Study location

NCT01826071 is a NA study of Osgood-Schlatter Syndrome (OSS) and Sinding-Larson and Johansson Syndrome (SLJ) that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 129 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01826071, a NA study of Osgood-Schlatter Syndrome (OSS) and Sinding-Larson and Johansson Syndrome (SLJ), has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

COMPLETED
Registry status
NA
Development phase
129 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare three different treatments for these types of lower extremity apophysitis- Osgood-Schlatter syndrome (OSS), Sinding-Larsen and Johansson syndrome (SLJ), or Sever's disease. The investigators hypothesize that adolescents who perform a home exercise program (HEP) consisting of active elongation exercises will have decreased pain and earlier return to sports and activities as compared to those who perform a HEP that consists of static stretching exercises or those who use symptomatic treatment with ice, acetaminophen or NSAIDs and activity modification.

Interventions

  • OTHER Static Stretch
  • OTHER Active Elongation

Study Locations (1)

Illinois

  • Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 129 participants
Start Date 2012-10
Est. Completion 2023-10
Phase NA

What the Registry Record Tells You About NCT01826071

The ClinicalTrials.gov registry entry for NCT01826071 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Osgood-Schlatter Syndrome (OSS) appearing as the primary indexed condition, and to 2 interventions - of which Static Stretch is the first listed.

NCT01826071 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01826071 about?

NCT01826071 is a clinical study titled "Comparison of Three Treatments for Lower Extremity Apophysitis". The purpose of this study is to compare three different treatments for these types of lower extremity apophysitis- Osgood-Schlatter syndrome (OSS), Sinding-Larsen and Johansson syndrome (SLJ), or Sever's disease. The investigators hypothesize that adolescents who perform a home exercise program (HE...

What is the current status of trial NCT01826071?

This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2012-10. Estimated completion is 2023-10.

What conditions does trial NCT01826071 study?

This clinical trial studies the following conditions: Osgood-Schlatter Syndrome (OSS), Sinding-Larson and Johansson Syndrome (SLJ), Sever's Disease, Apophysitis.

What interventions are being tested in trial NCT01826071?

The interventions under investigation include: Static Stretch (OTHER), Active Elongation (OTHER).

Who is sponsoring clinical trial NCT01826071?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01826071 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.